| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1.
|
Br J Pharmacol
|
2000
|
1.78
|
|
2
|
Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium.
|
Circ Res
|
1993
|
1.56
|
|
3
|
Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type.
|
Br J Pharmacol
|
1995
|
1.48
|
|
4
|
Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney.
|
Kidney Int
|
1993
|
1.22
|
|
5
|
Characterization of two new ETB selective radioligands, [125I]-BQ3020 and [125I]-[Ala1,3,11,15]ET-1 in human heart.
|
Br J Pharmacol
|
1992
|
1.17
|
|
6
|
Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system.
|
Br J Pharmacol
|
2007
|
1.11
|
|
7
|
Human endothelin receptors characterized using reverse transcriptase-polymerase chain reaction, in situ hybridization, and subtype-selective ligands BQ123 and BQ3020: evidence for expression of ETB receptors in human vascular smooth muscle.
|
J Cardiovasc Pharmacol
|
1993
|
1.01
|
|
8
|
Vasoconstrictor endothelin receptors characterized in human renal artery and vein in vitro.
|
Br J Pharmacol
|
1994
|
1.01
|
|
9
|
Effect of in vivo fetal infusion of dexamethasone at 0.75 GA on fetal ovine resistance artery responses to ET-1.
|
Am J Physiol Regul Integr Comp Physiol
|
2001
|
1.00
|
|
10
|
Differential distribution of endothelin peptides and receptors in human adrenal gland.
|
Histochem J
|
1996
|
0.96
|
|
11
|
[125I]-PD151242: a selective ligand for endothelin ETA receptors in human kidney which localizes to renal vasculature.
|
Br J Pharmacol
|
1994
|
0.93
|
|
12
|
Cellular expression of isoforms of endothelin-converting enzyme-1 (ECE-1c, ECE-1b and ECE-1a) and endothelin-converting enzyme-2.
|
J Cardiovasc Pharmacol
|
2000
|
0.90
|
|
13
|
Endothelial cell-specific ETB receptor knockout: autoradiographic and histological characterisation and crucial role in the clearance of endothelin-1.
|
Can J Physiol Pharmacol
|
2010
|
0.88
|
|
14
|
Characterization of endothelin isoforms in human heart: endothelin-2 demonstrated.
|
J Cardiovasc Pharmacol
|
1993
|
0.87
|
|
15
|
Affinity and selectivity of PD156707, a novel nonpeptide endothelin antagonist, for human ET(A) and ET(B) receptors.
|
J Pharmacol Exp Ther
|
1997
|
0.86
|
|
16
|
Failure of BQ123, a more potent antagonist of sarafotoxin 6b than of endothelin-1, to distinguish between these agonists in binding experiments.
|
Br J Pharmacol
|
1996
|
0.86
|
|
17
|
Vasoconstrictor activity of novel endothelin peptide, ET-1(1 - 31), in human mammary and coronary arteries in vitro.
|
Br J Pharmacol
|
2001
|
0.86
|
|
18
|
Discovery of recently adopted orphan receptors for apelin, urotensin II, and ghrelin identified using novel radioligands and functional role in the human cardiovascular system.
|
Can J Physiol Pharmacol
|
2002
|
0.85
|
|
19
|
Expression of endothelin peptides and mRNA in the human heart.
|
Clin Sci (Lond)
|
1996
|
0.85
|
|
20
|
ETA receptors predominate in the human vasculature and mediate constriction.
|
J Cardiovasc Pharmacol
|
1995
|
0.85
|
|
21
|
Expression of endothelin(A) receptors in human gliomas and meningiomas, with high affinity for the selective antagonist PD156707.
|
Neurosurgery
|
1998
|
0.83
|
|
22
|
Characterization of endothelin receptors in human brain cortex, gliomas, and meningiomas.
|
J Cardiovasc Pharmacol
|
1995
|
0.83
|
|
23
|
Maternal dexamethasone increases endothelin-1 sensitivity and endothelin a receptor expression in ovine foetal placental arteries.
|
Placenta
|
2003
|
0.81
|
|
24
|
Characterization of [125I]-PD164333, an ETA selective non-peptide radiolabelled antagonist, in normal and diseased human tissues.
|
Br J Pharmacol
|
1998
|
0.81
|
|
25
|
Characterization of the snake venom ligand [125I]-DNP binding to natriuretic peptide receptor-A in human artery and potent DNP mediated vasodilatation.
|
Br J Pharmacol
|
2006
|
0.80
|
|
26
|
Endothelin-converting enzyme in the human vasculature: evidence for differential conversion of big endothelin-3 by endothelial and smooth-muscle cells.
|
J Cardiovasc Pharmacol
|
1998
|
0.80
|
|
27
|
[125I]-PD151242: a selective radioligand for human ETA receptors.
|
Br J Pharmacol
|
1994
|
0.78
|
|
28
|
Characterization of site-directed antisera against endothelin-converting enzymes.
|
J Cardiovasc Pharmacol
|
1998
|
0.75
|
|
29
|
Analysis of endogenous human endothelin peptides by high-performance liquid chromatography and mass spectrometry.
|
J Cardiovasc Pharmacol
|
1995
|
0.75
|
|
30
|
Potency of PD155080, an orally active ETA receptor antagonist, determined for human endothelin receptors.
|
J Cardiovasc Pharmacol
|
1995
|
0.75
|
|
31
|
Isolation of human cardiac endothelin receptors by a peptide-receptor mobility shift assay.
|
Clin Sci (Lond)
|
1993
|
0.75
|
|
32
|
Tissue-specific modulation of endothelin receptors in a rat model of hypertension.
|
J Cardiovasc Pharmacol
|
2000
|
0.75
|
|
33
|
Expression and characterization of the human endothelin-A-receptor in Pichia pastoris: influence of N-terminal epitope tags.
|
J Cardiovasc Pharmacol
|
2000
|
0.75
|